Macquarie Group LTD Infinity Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.18 - $1.91 $6,962 - $11,269	-5,900 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.01 - $2.78 $5,959 - $16,402	5,900 New	5,900 $7,000
Q1 2018 May 11, 2018	SELL	$1.8 - $2.74 $8,460 - $12,878	-4,700 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$1.22 - $3.73 $5,734 - $17,531	4,700	4,700 $10,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.